Identification of a Series of Compounds with Potent Antiviral Activity for the Treatment of Enterovirus Infections

被引：36

作者：

MacLeod, Angus M. ^{[1
]}

Mitchell, Dale R. ^{[1
]}

Palmer, Nicholas J. ^{[1
]}

de Poel, Herve Van ^{[1
]}

Conrath, Katja ^{[3
]}

Andrews, Martin ^{[3
]}

Leyssen, Pieter ^{[2
]}

Neyts, Johan ^{[2
]}

机构：

[1] BioFocus, Dept Med Chem, Cambridge CBIO 1XL, England

[2] Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Louvain, Belgium

[3] Galapagos NV, Generaal Wittelaan, B-2800 Mechelen, Belgium

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 07期

关键词：

antiviral; enterovirus; HCV; inhibitor; PI4KIII beta; C VIRUS-REPLICATION; RHINOVIRUS COLDS; DOUBLE-BLIND; EXACERBATIONS; PLECONARIL; INHIBITORS; EFFICACY; SAFETY; ALPHA; BETA;

D O I：

10.1021/ml400095m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Rhinovirus (genus enterovirus) infections are responsible for many of the severe exacerbations of asthma and chronic obstructive pulmonary disease. Other members of the genus can cause life-threatening acute neurological infections. There is currently no antiviral drug approved for the treatment of such infections. We have identified a series of potent, broad-spectrum antiviral compounds that inhibit the replication of the human rhinovirus, Coxsackie virus, poliovirus, and enterovirus-71. The mechanism of action of the compounds has been established as inhibition of a lipid kinase, PI4KIII beta. Inhibition of hepatitis C replication in a replicon assay correlated with enterovirus inhibition.

引用

页码：20 / 24

页数：5

共 19 条

[1]

[Anonymous], World Health Statistics 2008

[2] Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity [J].

Arita, Minetaro ;

Kojima, Hirotatsu ;

Nagano, Tetsuo ;

Okabe, Takayoshi ;

Wakita, Takaji ;

Shimizu, Hiroyuki .

JOURNAL OF VIROLOGY, 2011, 85 (05) :2364-2372

[3] Polio Eradication: Strengthening The Weakest Links [J].

Barrett, Scott .

HEALTH AFFAIRS, 2009, 28 (04) :1079-1090

[4] Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication [J].

Berger, Kristi L. ;

Cooper, Jacob D. ;

Heaton, Nicholas S. ;

Yoon, Rosa ;

Oakland, Todd E. ;

Jordan, Tristan X. ;

Mateu, Guaniri ;

Grakoui, Arash ;

Randall, Glenn .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) :7577-7582

[5] Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity [J].

Bianco, Annalisa ;

Reghellin, Veronica ;

Donnici, Lorena ;

Fenu, Simone ;

Alvarez, Reinaldo ;

Baruffa, Chiara ;

Peri, Francesco ;

Pagani, Massimiliano ;

Abrignani, Sergio ;

Neddermann, Petra ;

De Francesco, Raffaele .

PLOS PATHOGENS, 2012, 8 (03)

[6] Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication [J].

Borawski, Jason ;

Troke, Philip ;

Puyang, Xiaoling ;

Gibaja, Veronica ;

Zhao, ShanChaun ;

Mickanin, Craig ;

Leighton-Davies, Juliet ;

Wilson, Christopher J. ;

Myer, Vic ;

CornellaTaracido, Ivan ;

Baryza, Jeremy ;

Tallarico, John ;

Joberty, Gerard ;

Bantscheff, Marcus ;

Schirle, Markus ;

Bouwmeester, Tewis ;

Mathy, Joanna E. ;

Lin, Kai ;

Compton, Teresa ;

Labow, Mark ;

Wiedmann, Brigitte ;

Gaither, L. Alex .

JOURNAL OF VIROLOGY, 2009, 83 (19) :10058-10074

[7]

COME JM, 2002, LANCET, V359, P831

[8] Selective Inhibitors of Picornavirus Replication [J].

De Palma, Armando M. ;

Vliegen, Inge ;

De Clercq, Erik ;

Neyts, Johan .

MEDICINAL RESEARCH REVIEWS, 2008, 28 (06) :823-884

[9] An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus [J].

Feil, Susanne C. ;

Hamilton, Stephanie ;

Krippner, Guy Y. ;

Lin, Bo ;

Luttick, Angela ;

McConnell, Darryl B. ;

Nearn, Roland ;

Parker, Michael W. ;

Ryan, Jane ;

Stanislawski, Pauline C. ;

Tucker, Simon P. ;

Watson, Keith G. ;

Morton, Craig J. .

ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04) :303-307

[10]

Fleischer R, 2003, CLIN INFECT DIS, V37, P1722

← 1 2 →